QUESTCOR PHARMACEUTICALS INC 4
4 · QUESTCOR PHARMACEUTICALS INC · Filed Apr 19, 2005
Insider Transaction Report
Form 4
SIGMA TAU INTERNATIONAL SA
10% Owner
Transactions
- Other
8% Convertible Debenture
2005-04-15$2000000.00/sh(indirect: The 8% Convertible Debenture was directly held by Defiante Farmaceutica L.d.A.)Exercise: $1.58Exp: 2005-04-15→ Common Stock, no par value per share (1,265,822 underlying) - Other
Common Stock, no par value per share
2005-04-15−1,265,822→ 0 total(indirect: Shares underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A.)
Holdings
- 549,100(indirect: Shares directly held by Aptafin S.p.A.)
Common Stock, no par value per share
- 100,000(indirect: Shares directly held by Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.)
Common Stock, no par value per share
- 1,756,781(indirect: Shares directly held by Claudio Cavazza.)
Common Stock, no par value per share
- 1,756,782(indirect: Shares directly held by Paolo Cavazza.)
Common Stock, no par value per share
- 8,643,397
Common Stock, no par value per share
- 759,493(indirect: Shares directly held by Defiante Farmaceutica L.d.A.)
Common Stock, no par value per share
Footnotes (4)
- [F1]Sigma-Tau Finanziaria S.p.A. owns 100% of the capital stock of Sigma-Tau International S.A. (f/k/a Sigma-Tau Finance Holding S.A.) and 58% of the capital stock of Defiante Farmaceutica L.d.A. Sigma-Tau International S.A. owns 42% of the capital stock of Defiante Farmaceutica L.d.A. Claudio Cavazza owns, directly and indirectly, 60% of Sigma-Tau Finanziaria S.p.A. and Paolo Cavazza owns, directly and indirectly, 40% of Sigma-Tau Finanziaria S.p.A. Paolo Cavazza also owns, directly and indirectly, 100% of Aptafin S.p.A. Aptafin S.p.A. owns, directly and indirectly, 100% of Chaumiere - Consultadoria & Servicos SDC Unipessoal LDA.
- [F2]The shares were underlying the 8% Convertible Debenture held by Defiante Farmaceutica L.d.A., which matured on April 15, 2005.
- [F3]The 8% Convertible Debenture held by Defiante Farmaceutica L.d.A. was convertible into Common Stock, no par value per share, at any time prior to the maturity date of April 15, 2005.
- [F4]The 8% Convertible Debenture matured on April 15, 2005. Questcor Pharmaceuticals Inc. has advised Defiante Farmaceutica L.d.A. that the debenture will be repaid in full.